Skip to main content
. 2014 Nov 28;133(2):115–124. doi: 10.1590/1516-3180.2014.9150812

Table 2. Characteristics in 195 participants from the ELSA study according to sonogram parameters to identify hepatic steatosis.

Table 2.

Biomarkers and hepatic steatosis indexes are expressed as median (interquartile interval). Hepatic steatosis index (HIS) = [8 X (ALT/AST ratio) +BMI (+2. if female; +2 if diabetes mellitus)]. Fatty liver index (FLI) = (e 0.953*loge (triglycerides) + 0.139*BMI + 0.718*loge (GGT) + 0.053*waist circumference - 15.745)/(1 + e 0.953*loge (triglycerides) + 0.139*BMI + 0.718*loge (GGT) + 0.053*waist circumference - 15.745) * 100. 64-MDCT: 64-channel multidetector computed tomography. Anteroposterior diameter of the right hepatic lobe (mm) ≥ 119.5 (men) or ≥ 102.5 (women) was defined as suggestive of hepatic steatosis and < 119.5 (men) or < 102.5 (women) as absence of this condition. ELSA = Estudo Longitudinal de Saúde do Adulto - Brasil. *P-values were obtained from the chi-square test for categorical variables and from the Kruskal-Wallis or Mann-Whitney test for continuous variables; †P-value ≤ 0.001, ‡P-value ≤ 0.05.